Notification That Quarterly Report Will Be Submitted Late (nt 10-q)
January 14 2020 - 06:07AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C.
20549
|
FORM
12b-25
|
SEC FILE NUMBER
|
|
|
000-55852
|
|
NOTIFICATION OF LATE
FILING
|
CUSIP NUMBER
|
|
|
39809D102
|
(Check One):
|
o
|
Form 10-K
|
o
|
Form 20-F
|
o
|
Form 11-K
|
x
|
Form 10-Q
|
|
o
|
Form 10-D
|
o
|
Form N-SAR
|
o
|
Form N-CSR
|
|
|
|
|
|
|
|
|
|
|
|
|
For Period Ended: November 30,
2019
|
|
|
|
|
o
o
o
o
o
|
Transition Report on Form 10-K
Transition Report on Form 20-F
Transition Report on Form 11-K
Transition Report on Form 10-Q
Transition Report on Form N-SAR
|
|
|
|
|
For the Transition Period Ended:
_____________________
|
Read Instructions (on back page) Before
Preparing Form. Please Print or Type.
NOTHING IN THIS FORM
SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION HAS VERIFIED ANY
INFORMATION CONTAINED HEREIN.
If the notification relates
to a portion of the filing checked above, identify the Item(s) to
which the notification relates:
PART I -- REGISTRANT
INFORMATION
Full Name of Registrant:
|
GridIron BioNutrients, Inc.
|
Former Name if Applicable:
|
None
|
Address of Principal Executive Offices
(Street and Number):
|
2701 Northgate Lane., Ste. 1G, Carson
City, Nevada 89706
|
PART II - RULES 12b-25(b)
AND (c)
If the subject report could
not be filed without unreasonable effort or expense and the
registrant seeks relief pursuant to Rule 12b-25(b), the following
should be completed (Check box if appropriate)
|
|
(a)
|
The reasons described in reasonable detail
in Part III of this form could not be eliminated without
unreasonable effort or expense;
|
|
|
|
|
x
|
|
(b)
|
The subject annual report, semi-annual
report, transition report on Form 10-K, Form 20-F, Form 11-K, Form
N-SAR or Form N-CSR, or portion thereof, will be filed on or before
the fifteenth calendar day following the prescribed due date; or
the subject quarterly report or transition report on Form 10-Q or
subject distribution report on Form 10-D, or portion thereof, will
be filed on or before the fifth calendar day following the
prescribed due date; and
|
|
|
|
|
|
|
(c)
|
The accountant's statement or other exhibit
required by Rule 12(b)-25(c) has been attached if applicable.
|
PART III --
NARRATIVE
State below in reasonable detail why Forms
10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition
report or portion thereof, could not be filed within the prescribed
time period.
The Registrant has been unable, without
unreasonable effort or expense, to timely compile all information
for the financial statements and related disclosures required to be
included in its Quarterly Report on Form 10-Q for the fiscal
quarter ended November 30, 2019.
PART IV --OTHER
INFORMATION
(1) |
Name and telephone number of person to contact in
regard to this notification: |
Timothy Orr
|
|
(800)
|
|
570-0438
|
Name
|
|
Area Code
|
|
Telephone Number
|
(2) |
Have all other periodic reports required under
Section 13 or 15(d) of the Securities Exchange Act of 1934 or
Section 30 of the Investment Company Act of 1940 during the
preceding 12 months or for such shorter period that the registrant
was required to file such report(s) been filed? If answer is no,
identify report(s). x
Yes o No |
|
|
(3) |
Is it anticipated that any significant change in
results of operations from the corresponding period for the last
fiscal year will be reflected by the earnings statements to be
included in the subject report or portion thereof? o Yes x No |
If so, attach an explanation of the
anticipated change, both narratively and quantitatively, and, if
appropriate, state the reasons why a reasonable estimate of the
results cannot be made.
GridIron BioNutrients,
Inc.
(Name of Registrant as
Specified in Charter)
has caused this notification to be signed on
their behalf by the undersigned hereunto duly authorized.
Date: January 13, 2020
|
By:
|
/s/ Timothy Orr
|
|
|
|
Timothy Orr
|
|
Instruction: The form may be
signed by an executive officer of the registrant or by any other
duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature.
If the statement is signed on behalf of the registrant by an
authorized representative (other than an executive officer),
evidence of the representative's authority to sign on behalf of the
registrant shall be filed with the form.
ATTENTION
INTENTIONAL MISSTATEMENTS OR
OMISSIONS OF FACT CONSTITUTE FEDERAL CRIMINAL VIOLATIONS (SEE 18
U.S.C. 1001).
|
Gridiron Bionutrients (QB) (USOTC:GMVP)
Historical Stock Chart
From Dec 2020 to Jan 2021
Gridiron Bionutrients (QB) (USOTC:GMVP)
Historical Stock Chart
From Jan 2020 to Jan 2021